Cargando…

SUN-040 Hormone Replacement Therapy in Transgender Unmasks Testicular Tumor

Introduction In transwomen, hormonal replacement therapy typically usually consists of anti-androgen and/or estrogens. Per Endocrine Society 2017 guidelines, patients should be evaluated every 3 months in the first year for appropriate signs of feminization and adverse reactions. This includes measu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Kelvin, Elshimy, Ghada, Correa, Ricardo Rafael, Harman, Sherman Mitchell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207975/ http://dx.doi.org/10.1210/jendso/bvaa046.1188

Ejemplares similares

MON-LB040 Correlation Between Length of Hormone Therapy and Adverse Events in Transgender Veterans
por: Elliott, Karma-Jaya, et al.
Publicado: (2019)

SUN-LB040 Associations of Testosterone and Sex Hormone Binding Globulin with the Risk of Cardiovascular Disease and Type 2 Diabetes in Men
por: Wittert, Gary, et al.
Publicado: (2019)

SUN-048 Cardiometabolic Effects of Cross-Sex Hormone Therapy in Transgender Patients
por: Trebotic, Lana Kosi, et al.
Publicado: (2020)

SUN-LB8 Cross Sex Hormone Therapy and Breast Cancer in Transgender Male to Female
por: Eldin, Randa Sharag, et al.
Publicado: (2020)

SUN-052 Effects of Cross-Sex Hormone Therapy on Lipid Metabolism in Transgender Women and Men
por: Kelley, Carly, et al.
Publicado: (2020)

SUN-043 Galactorrhea and Hyperprolactinemia in a Transgender Female
por: Unnithan, Rachna, et al.
Publicado: (2020)

SUN-LB9 Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women
por: Doll, Elizabeth E, et al.
Publicado: (2020)

SUN-050 Isolated Hyperprolactinemia Caused by Chest Binding in a Transgender Male
por: Cunningham, Hayley E, et al.
Publicado: (2020)

MON-040 11-Oxygenated C19 Steroids in Polycystic Ovarian Syndrome
por: Mody, Armaiti, et al.
Publicado: (2020)

SUN-041 Hispanic Medical Student’s Knowledge and Attitudes Towards Transgender Patient’s Care
por: Muns, Sofía, et al.
Publicado: (2020)

SUN-LB045 Microfluidic and Static Culture of Human Testicular Tissue
por: Edmonds, Maxwell, et al.
Publicado: (2019)

SUN-027 Testicular Regression Syndrome, an Underdiagnosed Cause of Hypergonadotropic Hypogonadism
por: Canales-Ramos, Nicolle M, et al.
Publicado: (2020)

SUN-042 Low Dose Cyproterone Acetate for the Treatment of Transgender Women - a Retrospective Study
por: Even-Zohar, Naomi, et al.
Publicado: (2020)

SUN-210 Testosterone Replacement Therapy Implicated in Osteonecrosis
por: Yang, Almira, et al.
Publicado: (2019)

SAT-040 Changes in Metabolic Parameters After Administration of Novel Oral Androgens with Progestational Activity for 28 Days
por: Yuen, Fiona, et al.
Publicado: (2020)

SUN-219 Human Congenital Arhinia Is Associated with GnRH Deficiency and Primary Testicular Defects
por: Delaney, Angela, et al.
Publicado: (2019)

SUN-047 Cosmetic Injection of Silicone in a Transgender Person Leading to Granulomatous Disease with Hypercalcemia and Terminal Kidney Failure
por: Pereira, Cecilia, et al.
Publicado: (2020)

Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

SUN-693 What Else Should Be Done in Patients with Uncontrolled Type 2 Diabetes and Severe Insulin Allergy?
por: Elshimy, Ghada, et al.
Publicado: (2020)

SUN-231 Marijuana Use Correlates with Hormonal Imbalance in Infertile Men
por: Teixeira, Thiago, et al.
Publicado: (2019)

SUN-002 Hormonal Profile of Ovarian Sertoli-Leydig Cell Tumor
por: Torchinsky, Michael Yuri, et al.
Publicado: (2020)

SUN-LB038 Rate and Extent of Testicular Function Recovery after Ceasing Non-Prescribed Androgen Abuse
por: Shankara Narayana, Nandini, et al.
Publicado: (2019)

SUN-049 Male Pattern Baldness and Waist-Hip Ratio as Markers of Arterial Stiffness in Transgender Men Undergoing Long-Term Testosterone Therapy
por: Alvares, Leonardo Azevedo Mobilia, et al.
Publicado: (2020)

SAT-LB040 Measuring LH Pulsatility in Patients with Reproductive Disorders Using a Novel Robotic Aptamer-Enabled Electrochemical Reader (RAPTER)
por: Dhillo, Waljit, et al.
Publicado: (2019)

SUN-220 The Effect of Testosterone Nasal Gel on Reproductive Hormones and Semen Parameters
por: Masterson, Thomas, et al.
Publicado: (2019)

Patient Characteristics Associated With the Receipt of Hormone Therapy Among Transgender Patients in the Veterans Health Administration
por: Wong, Denise H, et al.
Publicado: (2021)

ODP414 Incidence of Suicidal Events in Transgender Patients with Initiation of Gender Affirming Hormone Therapy
por: Elliott, Karma-Jaya, et al.
Publicado: (2022)

SUN-202 Seasonal Reduction of Grey Squirrel Testis Size Is Produced by Mechanisms Distinct from Age Onset Testicular Regression
por: Stratton, Lucie, et al.
Publicado: (2019)

MON-197 Peri-operative Outcomes of Vaginoplasty Using an Individualized Approach to Hormone Management in Transgender Women
por: Davidge-Pitts, Caroline, et al.
Publicado: (2019)

Muscle Strength in Transgender Women After Long-Term Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

Body Composition of Transgender Women After Long-Term Hormone Therapy - a Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

SUN-215 Phosphorylation Site of Gonadotropin Regulated Testicular RNA Helicase (GRTH/DDX25) and GRTH/PKA Binding Interface: Biochemical and Structural Studies
por: Raju, Murugananth Kumar, et al.
Publicado: (2019)

OR27-05 Sexual Desire Changes in Transgender Individuals upon Initiation of Hormone Treatment; Results from the Longitudinal ENIGI Study
por: Defreyne, Justine, et al.
Publicado: (2020)

Cardiovascular Risk Factors in Transgender Women Undergoing Long-Term Gender-Affirming Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

SUN-239 A Case with Elevated Serum Follicle-Stimulating-Hormone (FSH) Concentrations Due to Macro-FSH
por: Hattori, Naoki, et al.
Publicado: (2019)

A Cross Sectional Analysis of the Prevalence of Co-Morbidities in Older Transgender Individuals Receiving Hormone Affirming Therapy in Comparison With the General Population
por: Breda, Ido, et al.
Publicado: (2021)

First Evidence of Cardiopulmonary Adaptation to Physical Effort in Transgender Women After Long-Term Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sv8nckkidaioqaldlhma7l5tmi